Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma
Clinical trial NCT03572582 · COMPLETED
Trial details
- NCT number
- NCT03572582
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2021-10-12
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.